Kinetic variable most useful for identifying malignant MRI-detected breast lesions identified

Aug 19, 2009

Breast MRI allows physicians to evaluate suspicious lesions using a variety of variables. Researchers have found though that computer-aided kinetic information can help significantly in distinguishing benign from malignant suspicious breast lesions on MRI, according to a study published in the September issue of the American Journal of Roentgenology (AJR).

In the study, performed at the University of Washington Medical Center, researchers analyzed and compared the computer-aided evaluation variables of 125 suspicious breast lesions. Three different kinetic curves (washout, plateau and persistent), were compared along with lesion morphology (size and shape). "We wanted to clarify which, of the many variables that reflect kinetics, were most predictive of malignancy, said Constance Lehman, MD, lead author of the study. "We found overlap in kinetic patterns across benign and , but we did determine that the "most suspicious" curve type, washout, was useful in separating benign from malignant lesions," said Dr. Lehman.

"Of lesions with the most suspicious curve type (any washout), 45.7 percent were malignant compared with 20.0 percent with plateau and 13.3 percent with entirely persistent enhancement," she said.

"We continue to study the specific features on MRI most predictive of . We know that the morphology of the lesion is extremely important, but our study also supports the use of kinetic features in lesion assessment. The "most suspicious" curve, washout, does seem to help distinguish benign from malignant lesions," said Dr. Lehman.

"In breast MRI, it is important to know which variables are most important for predicting malignancy because they help us in determining whether or not a lesion needs to be biopsied or not," she said.

More information: This study appears in the September issue of the American Journal of Roentgenology.

Source: American Roentgen Ray Society

Explore further: FTC clears Sun Pharma's $4B purchase of competitor Ranbaxy

add to favorites email to friend print save as pdf

Related Stories

Melanomas may appear noticeably different than other moles

Jan 21, 2008

A preliminary study suggests that melanomas have a different appearance than other irregular skin moles (i.e., are “ugly ducklings”), according to a report in the January issue of Archives of Dermatology, one of the JAMA/Archives ...

Recommended for you

Why aren't there any human doctors in Star Wars?

8 hours ago

Though set "a long time ago in a galaxy far, far away," it isn't hard to see in the Star Wars films a vision of our own not so distant future. But Anthony Jones, a physician with a long background in health ...

Cambodia bans 'virgin surgery' adverts

Jan 29, 2015

The Cambodian government has ordered a hospital to stop advertising so-called virginity restoration procedures, saying it harms the "morality" of society.

What's happening with your donated specimen?

Jan 28, 2015

When donating blood, plasma, human tissue or any other bodily sample for medical research, most people might not think about how it's being used. But if you were told, would you care?

Amgen tops Street 4Q forecasts

Jan 27, 2015

Amgen Inc. cruised to a 27 percent jump in fourth-quarter profit and beat Wall Street expectations, due to higher sales of nearly all its medicines, tight cost controls and a tax benefit.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.